Search All Resources
HCV 101 | June 24, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hcv 101 #primary care #test and treat
In this presentation, Dr. Mera discusses screening, treatment and management of patients with hepatitis C in primary care and provides an opportunity to become part of a learning community.
Date added: 06/2/26
HCV Diagnosis and Linkage to Care in One Visit: HCV RNA PoC Testing in Action | June 3, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #HCV RNA POC #implementation #test and treat
In this presentation, Dr. Mera highlights how hepatitis C virus (HCV) diagnosis and linkage to care can be achieved in a single visit through the use of HCV RNA point-of-care (PoC) testing. He reviews real-world implementation strategies and demonstrates how ...
Date added: 05/29/26
Substance Use Disorders: Brains, Behavior and Diagnosis | May 27, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #addiction #neuroadaptation #neurobiology #SUD
In this presentation, Dr. Gregg reviews diagnostic criteria for substance use disorders and outlines the neurobiology of addiction, focusing on reward circuitry, neuroadaptation, and loss of control.
Date added: 05/15/26
Public Health Pharmacists Ending The Syndemic at Crow/Northern Cheyenne | May 20, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hiv #patient centered medical home #sti #SUD
In this presentation, Dr. Casey Marlin, and Marlaina Renney, summarize steps taken to establish an effective Patient Centered Medical Home clinic model, explain team member roles and workflow, and describe current clinic status and future goals to end the HIV/STI/HCV/SUD ...
Date added: 05/14/26
Hepatocellular Carcinoma (HCC) in HCV: Screening and Surveillance | June 17, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcc #hcv #prevention #surveillance
In this presentation, Dr. Deming reviews the screening and prevention guidelines for hepatocellular carcinoma (HCC), describes the recommendations for HCC screening and discusses the significance of on-going surveillance.
Date added: 05/6/26
Syphilis-Diagnose, Stage and Treat | May 6, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #penecillin #staging #syphilis #treponemal
In this presentation, Dr. Gabrellas reviews the clinical stages of syphilis and highlights the key findings that distinguish each stage, along with how to accurately interpret treponemal and non-treponemal test results, including common pitfalls. She also outlines evidence-based treatment strategies ...
Date added: 04/23/26
Doxycycline Post-Exposure Prophylaxis | April 22, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #chlamydia #doxy #doxypep #doxyprep #syphilis
In this presentation, Andrew reviews current recommendations for Doxycycline Post-Exposure Prophylaxis (DoxyPEP) prescribing, describes evidence that led to current DoxyPEP guidelines and reviews research studies in progress or on the horizon that may expand DoxyPEP eligibility.
Date added: 04/7/26
Providing Buprenorphine in Primary Care | April 15, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #buprenorphine #opioid use disorder #OUD
In this presentation, Dr. Robbins reviews the diagnostic criteria for substance use disorders (SUDs) and the underlying neurobiology of addiction. Furthermore, he provides an overview of office-based medications for the treatment of opioid use disorder.
Date added: 04/2/26
Updates from AASLD 2025 | April 1, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #daa #dementia #drug induced liver injury #encephalopathy #hcv #sofosbuvir #velpatasvir #voxilaprevir
In this presentation, Dr. Paulina Deming, PharmD, PhC, reviews common causes of drug induced liver injury (DILI) in adults, identifies the overlap between hepatic encephalopathy and dementia and discusses emerging data in assessing SVR for patients with prior DAA treatment ...
Date added: 03/24/26
Hepatitis C: An Overview | March 9, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cure #daa #direct acting antiviral #hcv
In this training, Dr. Jorge Mera discusses the epidemiology of HCV, how to recognize clinical manifestations, ways to implement screening & interpret diagnostic tests, and how to develop treatment & prevention strategies.
Date added: 03/9/26
